APA (7th ed.) Citation

Hansen, A. R., Probst, S., Beauregard, J., Viglianti, B. L., Michalski, J. M., Tagawa, S. T., . . . Fleshner, N. E. Initial clinical experience with [177Lu]Lu-PNT2002 radioligand therapy in metastatic castration-resistant prostate cancer: Dosimetry, safety, and efficacy from the lead-in cohort of the SPLASH trial. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Hansen, Aaron R., et al. Initial Clinical Experience with [177Lu]Lu-PNT2002 Radioligand Therapy in Metastatic Castration-resistant Prostate Cancer: Dosimetry, Safety, and Efficacy from the Lead-in Cohort of the SPLASH Trial. Frontiers Media S.A.

MLA (9th ed.) Citation

Hansen, Aaron R., et al. Initial Clinical Experience with [177Lu]Lu-PNT2002 Radioligand Therapy in Metastatic Castration-resistant Prostate Cancer: Dosimetry, Safety, and Efficacy from the Lead-in Cohort of the SPLASH Trial. Frontiers Media S.A.